期刊文献+

使用枸橼酸铁铵抑制3D-MRCP图像中胃肠信号的初步研究 被引量:15

Preliminary Evaluation of the Gastrointestinal Signals Elimination in 3D-MRCP by Using Ferric Ammonium Citrate
下载PDF
导出
摘要 目的 评价使用枸橼酸铁铵后 3D MRCP图像的改善程度。方法 本组共收集MRCP病人 3 0例。在服用枸橼酸铁铵前、后以相同的采集参数对其行 3D MRCP成像。图像评价从胃肠信号消除情况和图像质量改善情况两方面进行。结果 使用造影剂后胃部的对比信噪比由 7.0 64± 3 .85 3降至 1.0 41± 0 .45 9,十二指肠则由 5 .494± 3 .916降至 1.93 1± 2 .3 17,两者的P值均小于 0 .0 0 1;MRCP的图像质量由造影前的 2 .83 3± 2 .0 5 2增至 9.13 3± 2 .0 3 0 ,P <0 .0 0 1。结论 使用枸橼酸铁铵几乎可完全消除 3D MRCP图像中的胃肠信号 ,明显改善图像质量。 Purpose To evaluate the elimination of the gastrointestinal signals in 3 dimensional magnetic resonance cholangiopancreatography (MRCP) after using Ferric Ammonium Citrate (FAC). Methods We performed 3D MRCP imaging on all thirty patients before and after FAC taken with the same parameters. Image assessment was based on the extent to which the gastrointestinal signals were eliminated and to which the image quality was improved. Results After administration, the CNR of stomach was decreased to 1.041±0.459 from primary 7.064±3.853 ( P <0.001), while the CNR of duodenum was 1.931±2.317 comparing with 5.494±3.916 ( P <0.001). The image quality was significantly elevated to 9.133±2.030 from primary 2.833±2.052 ( P <0.001). Conclusion The combined use of FAC and TI can effectively suppress gastrointestinal signals and improve image quality significantly in 3D MRCP. [
出处 《中国医学影像技术》 CSCD 2003年第6期762-764,共3页 Chinese Journal of Medical Imaging Technology
关键词 MRCP 枸橼酸 胃肠 初步研究 胃部 造影 服用 信号 图像质量 信噪比 Magnetic resonance cholangiopancreatography Invert time Ferric Ammonium Citrate Negative contrast agent Positive contrast agent
  • 相关文献

参考文献12

  • 1Wesbey GE, Brasch RC, Goldberg HI, et al. Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging: initial clinical experience[J]. Magn Reson Imaging, 1985, 3(1): 57.
  • 2Patten RM, Moss AA, Fenton TA, et al. OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging, safty and imaging characteristics[J]. JMRI, 1992,2(1):25-34.
  • 3Patten RM, Lo SK, Phillips JJ, et al. Positive bowel contrast agent for MR imaging of the abdomen: Phase Ⅱand Ⅲ clinical trials[J]. Radiology, 1993,189(1):227.
  • 4Kivelitz D, Gehl HB, Henck A, et al. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen, safty and diagnostic efficacy[J]. Acta Radiology, 1999,40(4):429.
  • 5Hirohashi S, Uchida H, Tanaka M, et al. Phase Ⅲ study of an oral abdominal contrast agent containing Ferric ammonium citrate for magnestic resonance imaging(OMR-12200)[J]. Diag Treat, 1992,80(3):168.
  • 6Malcolm PN, Brown JJ, Hahn PF, et al. The clinical value of Ferric ammonium citrate: a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen[J]. JMRI, 2000,12(5):702.
  • 7Yasuhiro O, Yoshihiro N, Kazuo M, et al. Ferric ammonium citrate-cellulose paste for opacification of the esophageal lumen on MRI[J]. Jounal of Computer Assistal Tomography,1996,20(3):455.
  • 8Takahar T, Saeki M, Nosaka S, et al. The use of high concentration of Ferric ammonium citrate(FAC) solution as a negative bowel contrast agent:application in MR cholangiography[J]. Nippon Acta Radiol, 1995,55(9):697.
  • 9Takahar T, Yoshikawa T, Saeki M, et al. High concentration of Ferric ammonium citrate(FAC) solution as a negative bowel contrast agent[J]. Nippon Igaku Hoshasen Gakkai Zasshi, 1995,55(6):425.
  • 10Hirohashi S, Hirohashi R, Uchida H, et al. MR cholangiography and MR urography:Improved enhancement with a negative oral contrast agent[J]. Radiology, 1997,203(1):281.

同被引文献100

引证文献15

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部